Clinical data | |
---|---|
Trade names | Mycamine |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Intravenous |
Drug class | Antifungal (echinochandin)[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 99.8% |
Metabolism | Via catechol-O-methyltransferase pathway |
Elimination half-life | 11–17 hours |
Excretion | 40% feces, <15% urine |
Identifiers | |
| |
Chemical and physical data | |
Formula | C56H71N9O23S |
Molar mass | 1270.28 g·mol−1 |
| |
(what is this?) (verify) |
Micafungin, sold under the brand name Mycamine, is an antifungal medication used to treat or prevent severe candidiasis.[1] It may also be used for aspergillosis.[2] It is given by gradual injection into a vein.[1]
Common side effects include low white blood cells, low red blood cells, low potassium, low calcium, nausea, liver problems, and fever.[1] Other side effects may include anaphylaxis and kidney problems.[2] Safety in pregnancy is unclear.[3] It is an echinochandin which stops the production of beta-1,3-glucan, an essential component of fungal cell walls.[1]
Micafungin was approved for medical use in the United States in 2005 and Europe in 2008.[2][1] It is available as a generic medication.[4] It is on the World Health Organization's List of Essential Medicines.[5] In the United States 7 doses of 100 mg costs about 370 USD.[4] This amount in the United Kingdom costs about £2,000.[6]
References edit
- ^ a b c d e f g h "Mycamine". Archived from the original on 10 March 2021. Retrieved 18 November 2021.
- ^ a b c "Micafungin Monograph for Professionals". Drugs.com. Archived from the original on 24 July 2021. Retrieved 18 November 2021. Cite error: The named reference "AHFS2021" was defined multiple times with different content (see the help page).
- ^ "Micafungin (Mycamine) Use During Pregnancy". Drugs.com. Archived from the original on 23 January 2021. Retrieved 18 November 2021.
- ^ a b "Micafungin Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 18 November 2021.
- ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ^ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 632. ISBN 978-0857114105.